Neuropsychiatric complications of HIV : a challenging health concern /

Neuropsychiatric Complications of HIV: A Challenging Health Concern examines these neuropsychiatric complications prevalent in those who are HIV positive, providing clinical correlation, translational significance, and details guides to neurocognitive assessment, brain imaging, and related neurophar...

Full description

Bibliographic Details
Corporate Author: ScienceDirect (Online service)
Other Authors: Singh, Anchal (Editor)
Format: eBook
Language:English
Published: [Place of publication not identified] : Academic Press, [2025]
Subjects:
Online Access:Connect to the full text of this electronic book
Table of Contents:
  • Intro
  • Neuropsychiatric Complications of HIV: A Challenging Health Concern
  • Copyright
  • Dedication
  • Contents
  • Contributors
  • Foreword
  • Preface
  • Acknowledgments
  • Chapter 1: The neurobiology of human immunodeficiency virus infections
  • Summary
  • Introduction
  • Clinical stages of HIV infection
  • Group I: Primary HIV infection
  • Group II: Asymptomatic phase
  • Group III: Persistent generalized lymphadenopathy
  • Group IV: Symptomatic HIV infection
  • Molecular biology of the HIV virus
  • Genetic diversity and HIV clades
  • HIV replication
  • NeuroAIDS
  • Neurotoxicity and neuro-invasion
  • Factors for NeuroAIDS
  • Anti-retroviral drugs
  • High-risk behavior
  • Co-infection and co-morbidities
  • Virus-related issues
  • Host-related issues
  • HIV latency and reservoir
  • Conclusions
  • Acknowledgments
  • References
  • Further reading
  • Glossary
  • Chapter 2: HIV-1-mediated neuropsychiatric complications: Diagnosis and management
  • Summary
  • HIV and its impact on global health
  • HIV-1 infection and neuropsychiatric complications
  • Mechanisms of HIV entry into the CNS
  • The concept of viral reservoirs in the brain
  • HIV-associated dementia
  • Co-infections and development of neurophysiological disorders
  • Methods for screening and diagnosis of HAND
  • Anti-retroviral therapy-mediated neuropsychiatric toxicity
  • Peripheral neuropathy
  • Myopathy
  • Lactic acidosis
  • Discussion of diagnostic challenges and treatment decisions
  • Diagnostic challenges
  • Treatment decisions
  • Mechanisms of pathogenesis
  • Treatment optimization
  • Precision medicine and personalized approaches
  • Health disparities and social determinants
  • Global perspectives and collaborative research
  • Multi-disciplinary care and management
  • Future directions and research
  • Conclusion
  • Acknowledgments
  • References
  • Glossary.
  • Chapter 3: Neuropsychiatric complications among elderly people living with HIV
  • Summary
  • What you expect to know
  • Introduction
  • HIV and neuropathology
  • HIV and psychoneuroimmunology
  • Clinical spectrum of neuropsychiatric complications among elderly people living with HIV
  • Classification and diagnosis of human immunodeficiency virus-associated neurocognitive disorder (HAND) phenotypes
  • Immune reconstitution inflammatory syndrome in the nervous system (NeuroIRIS)
  • NeuroAIDS
  • Depressive spectrum disorder
  • Mania
  • Anxiety
  • Psychotic disorders
  • Late HIV diagnosis
  • Treatment of neuropsychiatric complications among elderly patients with HIV
  • Tricyclic anti-depressants
  • Selective serotonin reuptake inhibitors
  • Newer anti-depressant agents
  • The way ahead
  • Acknowledgment
  • References
  • Glossary
  • Chapter 4: Epidemiology of neuropsychiatric complications in HIV
  • Summary
  • What you expect to know
  • Introduction
  • The multi-dimensional nexus of HIV and neuropsychiatric phenomena
  • HIV and the brain: A molecular odyssey
  • Genetic and environmental influences on cognitive risks in HIV
  • Challenges and impact: Unmasking disparities in neuropsychiatric burden
  • Unveiling gender disparities in HIV-related neuropsychiatric challenges
  • Mechanisms and strategies: Paving the road to precision interventions
  • Anti-retroviral therapy: A symphony of protection for cognitive function
  • Unveiling prevalence: Charting cognitive landscapes in the context of HIV
  • Navigating early shores: Early detection, strategic interventions, and beyond
  • Epilogue: Fusing scientific insight with compassionate care
  • Conclusion
  • Questions
  • References
  • Further reading
  • Glossary
  • Chapter 5: Role of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) genes in n
  • Summary
  • Introduction.
  • HIV-related proteins
  • Tropism of HIV infection
  • HIV and neurotoxicity
  • Pathogenesis of neuro-HIV
  • Development of neuro-HIV
  • Role of HIV-1 Tat protein in neurodegeneration
  • Diagnosis of dementia
  • HIV-associated dementia
  • HIV-1-associated neurological dementia
  • Genetic factors
  • Matrix metalloproteinases
  • Structure of MMPs
  • Classification of MMPs
  • Genetic variation in MMPs
  • TIMPs
  • The association between MMPs, TIMPs, and HAND
  • Genetic variation in MMPs and TIMPs genes and HAND
  • Therapy
  • Forthcoming prospective
  • Prospect suggestions
  • Acknowledgment
  • References
  • Further readings
  • Glossary
  • Chapter 6: Genetics and epigenetics of NeuroAIDS
  • Summary
  • Introduction
  • Genetic susceptibility to NeuroAIDS
  • Immune-related genes
  • CCR5 gene (C-C chemokine receptor type 5)
  • Genes encoding monocyte chemoattractant protein-1 (MCP-1 or CCL2)
  • CCL3 gene
  • Apolipoprotein Epsilon 4 allele (APOE4)
  • Dopamine-related genes
  • NeuroAIDS epigenetic studies
  • DNA methylation
  • Histone modification
  • miRNA regulation
  • Role of iron-mediated mitochondrial dysmetabolism in neuroHIV/AIDS patients
  • Genome-wide association studies (GWASs) in HAND
  • HIV-associated neural tube defects in children
  • WWW
  • Conclusion and future perspective
  • Acknowledgment
  • References
  • Further readings
  • Glossary
  • Chapter 7: Dementia and HIV infection
  • Summary
  • What you expect to know
  • A brief history and current diagnostic nomenclature of HIV-associated neurocognitive disorder
  • Clinical manifestations and cognitive profile of dementia
  • Diagnosis of HAD
  • Screening tests for HAD
  • Extensive neuropsychological testing
  • The role of comorbidities in HAD
  • Diagnostic procedures and workup
  • Differential diagnosis of HAD
  • Treatment of HAD
  • Conclusions
  • Questions
  • References
  • Further reading.
  • Chapter 8: BBB and neuroinflammation
  • Summary
  • Introduction
  • BBB and its protective role
  • BBB and its role in neuroinflammation
  • Components of BBB
  • Endothelial cells
  • Pericytes
  • Astrocytes
  • Therapeutics in neuroinflammation
  • Factors responsible for changing blood-brain barrier function: Development
  • Nutrition
  • Hypoxia
  • Temperature
  • Social and psychological stress
  • Environmental pollution
  • Effects of aging on blood-brain barrier
  • Diseases and blood-brain barrier
  • Alzheimer's disease and blood brain barrier
  • Multiple sclerosis and blood-brain barrier
  • Traumatic brain injury and blood-brain barrier
  • Ischemic stroke and blood-brain barrier
  • Conclusion
  • Acknowledgment
  • References
  • Further reading
  • Glossary
  • Chapter 9: Neurological manifestations and neuropharmacology of HIV/AIDS
  • Summary
  • Introduction
  • Neurological manifestation due to HIV
  • HIV-associated neurocognitive disorder
  • Neuropathogenesis of HAND
  • Clinical features
  • Aseptic meningitis
  • Cerebrovascular disease
  • Vacuolar myelopathy
  • Peripheral neuropathy
  • Myopathy
  • Neuropharmacology of anti-retroviral drugs
  • Neuropenetrance of anti-retroviral drugs
  • CNS toxicity of ART
  • NRTIs
  • NNRTIs
  • PIs
  • INSTIs
  • Entry inhibitors
  • Recent advances
  • Nano-ART
  • Conclusion
  • Essay-type questions
  • Short answer questions
  • World wide web resources
  • References
  • Glossary
  • Chapter 10: Traumatic brain injury: An emerging threat for HIV-associated neurocognitive disorder
  • Summary
  • Introduction
  • HIV-associated neurocognitive disorder
  • HIV proteins, neuroinflammation, and HAND
  • Aberrant neuronal signaling pathways associated with HAND
  • Potential risk factors for HAND
  • Traumatic brain injury as a potential co-morbidity in HIV patients and emerging risk factor for neurocognitive disorder.
  • Mice models to study the impact of TBI and HIV infection to brain
  • TBI models
  • CCI model
  • CHI model
  • FPI model
  • BI model
  • Mice models for HIV infection in the brain
  • Conclusion and future perspective
  • Questions
  • World wide web resources
  • References
  • Glossary
  • Chapter 11: Drosophila as a model to study NeuroHIV: Insights from sleep function
  • Summary
  • Introduction
  • Drosophila as model systems for HIV disease
  • Strengths of Drosophila as a general research model
  • Sleep disturbances and HIV infection
  • Sleep in the Drosophila immune system and potential applications for NeuroHIV
  • NEMURI linking sleep and immune function
  • Tob signaling in sleep regulation and its potential role in immune system
  • Draper signaling in sleep-related neuroprotection
  • Limitations of using Drosophila as a model for NeuroHIV
  • Conclusion
  • Questions
  • World wide web resources
  • References
  • Further reading
  • Chapter 12: Human immunodeficiency virus and antibodies: Catch 22
  • Summary
  • Introduction
  • Epitope accessibility by bnAbs
  • Neutralization breadth predictors/parameters
  • Broadly neutralizing antibodies from infants/children: A platform for potent neutralizers
  • Elucidation of molecular pathways in attaining neutralization breadth
  • HIV-1 broadly neutralizing antibodies in clinical development/trial
  • A glimpse at the history of bnAb development and their clinical utility
  • Ongoing clinical trials of bnAbs
  • Why bnAb combinations are preferred over their individual administration?
  • Antibody engineering: New hope for future as HIV therapeutics
  • Conclusion
  • Questions
  • References
  • Further reading
  • Chapter 13: Elite neutralizers: An open eye for HIV vaccine development
  • Summary
  • Introduction
  • Influence of viral diversification on bnAb selection.